Envestnet Asset Management Inc. Has $54.17 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Envestnet Asset Management Inc. trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 642,247 shares of the medical device company's stock after selling 30,142 shares during the period. Envestnet Asset Management Inc. owned approximately 0.32% of Cooper Companies worth $54,174,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Covestor Ltd boosted its stake in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after acquiring an additional 120 shares in the last quarter. Shell Asset Management Co. boosted its position in shares of Cooper Companies by 15.5% in the 4th quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock valued at $87,000 after purchasing an additional 127 shares during the period. UMB Bank n.a. boosted its position in shares of Cooper Companies by 16.7% in the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock valued at $76,000 after purchasing an additional 129 shares during the period. Mitchell & Pahl Private Wealth LLC boosted its position in shares of Cooper Companies by 1.8% in the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock valued at $732,000 after purchasing an additional 157 shares during the period. Finally, Nissay Asset Management Corp Japan ADV boosted its position in shares of Cooper Companies by 0.8% in the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 24,054 shares of the medical device company's stock valued at $2,221,000 after purchasing an additional 193 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Trading Down 0.1%

Shares of Cooper Companies stock traded down $0.05 during trading hours on Monday, hitting $74.72. The company's stock had a trading volume of 102,540 shares, compared to its average volume of 1,735,779. The Cooper Companies, Inc. has a 12 month low of $65.00 and a 12 month high of $112.38. The stock has a 50 day moving average of $74.92 and a 200 day moving average of $82.57. The company has a market capitalization of $14.94 billion, a PE ratio of 36.37, a price-to-earnings-growth ratio of 1.82 and a beta of 0.99. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. During the same period in the prior year, the company earned $0.85 earnings per share. The company's revenue for the quarter was up 6.3% compared to the same quarter last year. Analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. Wells Fargo & Company decreased their price target on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research report on Friday, May 30th. UBS Group raised Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. Loop Capital set a $100.00 price target on Cooper Companies in a report on Tuesday, June 17th. Robert W. Baird reduced their price target on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research report on Friday, May 30th. Finally, Needham & Company LLC raised Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price target for the company in a research report on Tuesday, June 17th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $99.70.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.